TG Therapeutics | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Alaunos Therapeutics USD 2.76M 795K 2024-12
Amgen USD 26.93B 2.1B 2025-03
Ardelyx USD 356.45M 72.35M 2024-12
Arrowhead Research USD 1.14B 564.68M 2025-03
Bayer EUR 34.83B 388M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Dynavax Technologies USD 815.97M 32.97M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
J&J USD 71.55B 15.66B 2025-03
Novartis USD 29.7B 1.56B 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



TG Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.